Common questions about Aurorix (FAQ)
Q: How quickly does Aurorix typically start to work?
Official information indicates that initial improvements in symptoms such as sleep, appetite, and energy may be observed within one to two weeks after treatment begins. Full clinical assessment of the medicine's effect is generally conducted after four to six weeks of treatment.
Q: Is it common to feel sleepy when starting Aurorix?
Regulatory documents note that the medicine may cause sleep disturbances or insomnia. Official product information suggests that caution is used when driving or operating heavy machinery if drowsiness or feeling slowed down occurs.
Q: Does Aurorix have sexual side effects?
The official product labeling does not list sexual dysfunction in the most common side effect categories. Studies comparing Aurorix to other antidepressant types suggest that the medicine tends to be associated with fewer reports of sexual dysfunction.
Q: How is Aurorix different from SSRIs?
Aurorix (Moclobemide) is formally categorized as a Reversible Inhibitor of Monoamine Oxidase A (RIMA). This is a targeted mechanism of action that works by temporarily blocking an enzyme called MAO-A, which is distinct from the mechanism of Selective Serotonin Reuptake Inhibitors (SSRIs).
Q: Are there any common foods to avoid when using Aurorix?
Official documentation advises caution and the avoidance of certain tyramine-containing foods, such as fermented cheese, cold cuts, beer, shrimp, organ meats, and red wine. These dietary cautions are noted in regulatory information to minimize the potential for an adverse reaction.
Q: Are there any research studies focusing on Aurorix for non-depression uses?
Official regulatory documents support the use of Aurorix for Social Anxiety Disorder (also called Social Phobia), in addition to its use in major depressive disorder. Studies have also examined its potential for other applications, such as smoking cessation.
Q: Can Aurorix affect blood pressure?
Regulatory warnings indicate a potential for a severe reaction known as a hypertensive crisis (rapid increase in blood pressure) if the medicine is combined with high-tyramine foods. The medicine is associated with this risk related to the context of food and other interactions.
Q: What is the official purpose of the black box warning on Aurorix packaging (if applicable)?
As an antidepressant, the most serious warnings associated with this drug class relate to the risk of suicidal thoughts and behaviors, particularly during the initial period of therapy. Some regulatory regions also subject the medicine to additional monitoring to enhance the reporting of potential adverse effects.
Q: What happens if I take Aurorix with cold or flu medicine?
The official product label explicitly prohibits taking Aurorix with the ingredient dextromethorphan. Dextromethorphan is a common component in many cough and cold medicines, and the combination carries an increased risk of Serotonin Syndrome.
Q: Does taking Aurorix require regular blood tests?
Official labeling states that laboratory tests may be done periodically while taking this medication. Periodic laboratory tests are noted in regulatory documents as a requirement for monitoring the patient during treatment.
Q: Can Aurorix be taken with stomach acid reducers?
Official documentation notes a significant interaction with Cimetidine, which is a type of stomach acid reducer. Because Cimetidine can inhibit liver enzymes and increase the level of Aurorix in the blood, regulatory guidance states that the dose of Aurorix must be reduced if the two are taken together.
Q: Are there any known allergic reactions to Aurorix?
Yes, a known hypersensitivity to the drug or its components is listed as an absolute contraindication for use. Allergic reactions may involve symptoms such as cough, shortness of breath, swelling of the face, rash, itching, or hives.
Q: Does Aurorix cause weight gain for most people?
In comparison to many other antidepressants, published data suggests that in short-term treatment, Aurorix has generally shown a tendency toward weight-neutrality or slight weight reduction. Long-term data regarding the incidence of weight changes has produced mixed results.
Q: Is Aurorix known to interact with caffeine or alcohol?
Official documents state that this drug may increase the effects of alcohol, which could result in increased sleepiness, dizziness, or lightheadedness. Core regulatory labels do not explicitly address an interaction with caffeine.
Q: Do I need to follow a special diet while taking Aurorix?
Dietary caution is advised in official product information regarding the avoidance of certain foods high in tyramine to prevent a severe reaction. Additionally, some regulatory documents state that if a dose is higher than 600 mg per day, special diet restrictions may be needed.
Q: What is the experience like when discontinuing Aurorix?
Withdrawal effects may occur within five days of stopping treatment, especially if discontinued suddenly. Reported symptoms may include effects such as muscle cramps, shivering, headache, nausea, and hot flushes. Regulatory instructions state that discontinuation should be gradual to minimize these effects.
Q: Does Aurorix require special monitoring by a doctor?
Yes, treatment with this medicine requires regular monitoring by a doctor and includes periodic laboratory tests to monitor effects.
Q: How does the half-life of Aurorix influence its use?
Aurorix has a short elimination half-life, typically around 2 to 4 hours. This characteristic is important because the enzyme inhibition it causes is rapidly reversible, meaning drug-drug interactions are considered unlikely to occur 24 hours after the medicine has been stopped.
Q: What should I know about driving while taking Aurorix?
Official information advises users to be careful when driving or operating machinery until they are certain of how the medicine affects them. This caution is advised because the medicine can potentially cause side effects such as dizziness or tiredness in some people.
